Increased cases of Rotavac-induced intussusceptions after the third dose explained by background rates
The third dose of vaccine is scheduled to be administered at 14 weeks of age, but children presented at a
Read MoreThe third dose of vaccine is scheduled to be administered at 14 weeks of age, but children presented at a
Read MoreTwo other self-controlled case series studies published in July 2020 and January 2021 also did not find Bharat Biotech’s Rotavac
Read MoreIf the most glaring limitation of the study is the lack of a control group, the absence of data on
Read MoreOn January 31, when 11 deaths of health-care and frontline workers were reported from across the country following administration of
Read More